GlassScriptPhysician profile
Katrin Heineman
NPI 1396305140
$6,287.28
in general payments reported to CMS, 2019-2025
22 companies · $2,396 in 2025
The $2,396 reported for 2025 was more than what 86% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $295 · 2024: $3,596 · 2025: $2,396.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,663 · Travel and Lodging: $2,625.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,662.63 |
| Travel and Lodging | $2,624.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,443.06 | 2023-2025 | Salvation, Hoffmann, Prostep Mica |
| Smith+Nephew, INC. | $1,013.61 | 2024-2025 | Stravix, Grafix Pl, Grafix |
| Arthrex, INC. | $640.30 | 2024 | |
| Eclipse Technology Solutions INC. | $496.45 | 2024 | |
| Kerecis Limited | $145.70 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Treace Medical Concepts, INC. | $53.32 | 2024 | |
| Organogenesis INC. | $53.25 | 2024 | Affinity |
| Paratek Pharmaceuticals, INC. | $48.31 | 2024 | Nuzyra |
| Abbvie INC. | $46.53 | 2024 | |
| Bonalive INC | $44.24 | 2025 | |
| Zimmer Biomet Holdings, INC. | $37.66 | 2024 | Tapestry |
| Urgo Medical North America, LLC | $34.62 | 2024 | Urgok2 |
| Bioventus LLC | $33.05 | 2025 | Exogen Ultrasound Bone Healing System |
| Next Science LLC | $30.02 | 2023 | Surgx, Blastx, Xperience |
| Acumed LLC | $26.66 | 2023 | Osteomed |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solventum Corporation | $21.90 | 2024 | Activ.A.C., 3m Coban |
| Integra Lifesciences Corporation | $21.28 | 2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $20.85 | 2024 | Jublia |
| Depuy Synthes Sales INC. | $20.75 | 2025 | Va-Lcp |
| Ibsa Pharma INC. | $20.72 | 2024 | Tirosint, Licart |
| Reddress USA, INC. | $20.48 | 2023 | |
| Medtronic, INC. | $14.52 | 2024 | Closurefast |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katrin Heineman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.